Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03263572 |
|---|---|
| Brief Title: | Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia |
| First Submitted : | August 24, 2017 |
| First Submitted that Met QC Criteria : | August 24, 2017 |
| First Posted : | August 28, 2017 |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |